Skip to main content

Health economic modeling for medical technologies in Europe

Early and comprehensive economic models to determine economic value proposition and inform healthcare decision-makers

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Regular update of the Norwegian Laboratory Code System released

In late March 2023, the Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system (Norsk laboratoriekodeverk 7280.67) and associated tariffs for state and private laboratories to be implemented no later than May 1, 2023.

NLK system is for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) for laboratory tests performed in outpatient settings.

Twenty-one new codes were added to NLK in medical biochemistry, immunology and transfusiology, clinical pharmacology, and medical microbiology. Some examples of the newly-added codes are:

  • NPU56023 Sp-Kappa chains, free (spinal fluid);
  • NPU61114 ctDNA(P)-Microsatellite instability (MSI) (plasma);
  • NOR35276 U-Organic acids/Creatinine (list) (urine);
  • NPU61109 B-BAT CD63 Diclofenac-induced (blood);
  • NPU61099 P-Toxocara IgG (plasma).

See more information in Norwegian here (codes) and here (tariffs).

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.